Insiders · Profile

LANGER DENNIS

Director at Quoin Pharmaceuticals · Director at MYRIAD GENETICS. Filing since 19 Dec 2007. CIK 0001274225

Company
Date
Role
Action
Shares
Amount
Of holding
14 Oct 2025
Director
Bought
15,152
$128.64K
×15,152
7 Jun 2024
Director
Sold at will
297
$217.40
84.9%
3 Aug 2021
Director
Sold, plan not stated
30,000
$1.04M
25.1%
8 Jun 2018
Director
Sold, plan not stated
13,664
$537.68K
25.6%
7 Jun 2018
Director
Sold, plan not stated
3,096
$121.83K
7.2%
6 Jun 2018
Director
Sold, plan not stated
3,609
$142.09K
8.3%
5 Jun 2018
Director
Sold, plan not stated
1,227
$48.96K
3.0%
4 Jun 2018
Director
Sold, plan not stated
18,404
$734.32K
31.7%
1 Jun 2018
Director
Sold, plan not stated
30,000
$1.17M
43.0%
30 May 2018
Director
Sold, plan not stated
10,000
$379.25K
20.1%
21 May 2018
Director
Sold, plan not stated
10,000
$359.00K
20.1%
30 Nov 2012
Director
Sold, plan not stated
45,000
$1.35M
100%
29 Nov 2012
Director
Sold, plan not stated
25,000
$745.50K
100%
5 Feb 2009
Director
Sold, plan not stated
15,000
$1.24M
100%
5 Sep 2008
Director
Sold, plan not stated
4,280
$271.78K
100%
4 Sep 2008
Director
Sold, plan not stated
5,720
$375.97K
100%
20 Dec 2007
Director
Sold, plan not stated
20,000
$951.85K
100%
19 Dec 2007
Director
Sold, plan not stated
10,000
$475.13K
100%
18 decisions on file.